MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Penumbra Operating Cycle 2011-2026 | PEN
Annual Operating Cycle Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 378 | 386 | 420 | 422 | 385 | 378 | 389 | 344 | 360 | 354 | 393 | 346 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 422 | 344 | 380 |
Quarterly Operating Cycle Penumbra
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 390 | 380 | 389 | 405 | 318 | 427 | 429 | 411 | 420 | - | 227 | 200 | 383 | 360 | 362 | 379 | 432 | 339 | 402 | 598 | 418 | 363 | 390 | 419 | 342 | 312 | 350 | 340 | 321 | 323 | 360 | 358 | 364 | 305 | 333 | 343 | 386 | 338 | 359 | 410 | 393 | 314 | 157 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 598 | 157 | 363 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
136 | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
205 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
216 | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
314 | $ 9.2 | 2.45 % | $ 330 M | USA |
 |
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
270 | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
357 | - | - | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Electromed
ELMD
|
228 | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Helius Medical Technologies
HSDT
|
381 | $ 2.16 | 7.46 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
265 | $ 9.55 | 0.1 % | $ 735 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
83.5 | $ 6.42 | 1.58 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
170 | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
259 | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Cytosorbents Corporation
CTSO
|
175 | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
181 | $ 63.3 | 1.44 % | $ 3.45 B | Britain |
 |
InspireMD
NSPR
|
248 | $ 1.77 | -1.12 % | $ 114 M |  Israel |
 |
LENSAR
LNSR
|
213 | $ 5.58 | 0.36 % | $ 64.3 M | USA |
 |
AdaptHealth Corp.
AHCO
|
64 | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Medtronic PLC
MDT
|
237 | $ 87.89 | 1.51 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
180 | $ 4.1 | -0.73 % | $ 606 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
32.1 | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
289 | - | - | $ 24.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
793 | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Myomo
MYO
|
117 | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
NanoVibronix
NAOV
|
885 | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
351 | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Orthofix Medical
OFIX
|
318 | $ 11.93 | 1.79 % | $ 472 M |  Curacao |